The Impact of PFAS Restrictions on the Pharmaceutical Industry

The Impact of PFAS Restrictions on the Pharmaceutical Industry

PFAS, or per- and polyfluoroalkyl substances, are a group of man-made chemicals used in a wide range of common products, including non-stick cookware and water-repellent fabrics. PFAS have been linked to various environmental risks and health concerns, including cancer, reproductive and developmental issues, and immune system disruption.

PFAS are extremely persistent in the environment; they do not break down easily and can travel long distances when released. Studies have shown that these chemicals can bioaccumulate in humans and wildlife, meaning that they can build up in the body over time. According to research, this can lead to long-term health effects – including cancer, thyroid conditions, and infertility – and negative environmental impacts. They are classified as “forever chemicals”.

These chemicals can enter the environment not only through industrial processes, wastewater, and the improper disposal of consumer products, but also in life sciences settings. PFAS can actually be found in many of the common fluoropolymers used in the manufacture of medical devices and containers. The pharmaceutical industry in particular has come under fire as of late, specifically in Europe – where a sweeping PFAS restriction is looming.

 

Our Approach to PFAS at Savillex

The proposed restriction of PFAS in the European Union – and potential for a full ban of all PFAS by 2027 – would have a detrimental impact on pharmaceutical manufacturing throughout Europe. To learn more about the impact the restriction could have on the industry, read this European Pharmaceutical Review article.

The goals of regulations being considered are to limit the impact of substances that can harm people and the environment. Savillex fully supports discussion around limiting the use of substances that cause negative environmental impact.

However, according to the American Chemistry Council’s Performance Fluoropolymer Partnership, the fluoropolymer plastics processed by Savillex satisfy widely accepted assessment criteria to be considered “polymers of low concern”. Furthermore, it is not scientifically appropriate to group fluoropolymers with other PFAS classes.

In our official PFAS Position Statement, you will find that Savillex is committed to:

1. Providing information to stakeholders regarding PFAS so that thoughtful, informed discussion is possible
2. Working with supply chain partners to ensure environmental stewardship is promoted during the manufacture of fluoropolymer plastics used by Savillex
3. Continuously improving our efforts to capture and reuse fluoropolymer plastics processed by Savillex
4. Encouraging best practices for end-of-life handling of fluoropolymer products

 

Our full PFAS Position Statement can be found here. Please feel free to contact us at info@savillex.com with any questions.